# A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

> **NCT06578078** · PHASE3 · RECRUITING · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 94 (estimated)

## Conditions studied

- Heart Failure
- Chronic Kidney Diseases

## Interventions

- **DRUG:** Sodium Zirconium Cyclosilicate
- **DRUG:** Standard of care treatment (RAASi therapy)

## Key facts

- **NCT ID:** NCT06578078
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-03
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06578078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06578078, "A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06578078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*